FMI greatly appreciates the actions FDA has taken to date toward the development of an enhanced approach to conducting Post-Market Assessments of chemicals in food.  We have been actively engaged throughout the process since the August 2024 publication of the FDA Discussion Paper outlining the proposed process and the September 25, 2025 Public Meeting hosted by FDA.  To reiterate the oral comments we delivered at the Public Meeting, and the written comments we submitted to Docket No. FDA-2024-N-3609 (incorporated by reference herein), FMI and its members are committed to ensuring a safe food supply and we welcome FDA’s efforts to engage in Post-Market Assessments of chemicals in food using an approach that is both transparent and grounded in sound science. 

FMI supports having a basic framework for prioritizing chemicals for risk assessment, as it would enable the agency to evaluate how it will use its resources effectively and efficiently.  At the same time, FMI would welcome additional detail and specificity regarding the agency’s use of the Tool within the wider process for Post-Market Assessment, so it and other stakeholders can fully understand how the process will work in practice and to ensure that the process is transparent, science-based, and applied consistently to maximize benefit for the U.S. consumer.  

Full Comments